参考文献/References:
[1]中华人民共和国卫生部.手足口病预防控制指南(2009年版)[EB/OL].[2019-05-06].http://www.gov.cn/gzdt/2009-06/04/content_1332078.html. [2]南海,李晓琪,林忠义.2008~2016年浙江省永嘉县手足口病病例及病原分布特征[J].上海预防医学,2018,30(1):59-62. [3]张晓玲,俞慧菊,宋志刚,等.上海地区2011~2014年手足口病的病原谱变化及流行规律分析[J].上海预防医学,2018,30(5):380-385. [4]赵善露,罗垲炜,胡世雄,等.湖南省2008-2015年手足口病暴发疫情流行特征分析[J].中国热带医学,2016,16(9):890-892,900. [5]中华人民共和国卫生部.手足口病诊疗指南(2010年版)[EB /OL].[2019-05-06].http://www.nhfpc.gov.cn/yzygj/s3593g/201306/6d935c0f43cd4a1fb46f8f71acf8e245.shtml. [6]中华人民共和国卫生部.手足口病聚集性和暴发疫情处置工作规范(2012年版)[EB/OL].[2019-05-06].http://www.nhfpc.gov.cn/jkj/s3577/201206/. [7]李萌,张清慧,郭晓芹.2012-2016年上海市松江区手足口病流行病学及病原学特征分析[J].现代预防医学,2017,44(18):3421-3425. [8]周芳芳,于永.2011-2014年南京市栖霞区手足口病发病与气候因素的关系[J].医学与社会,2016(8):54-56. [9]王宇倩,洪志敏,王晓磊,等.呼和浩特市暖季气象因素对手足口病发病的影响[J].病毒学报,2020,36(6):83-90. [10]王金明,路滟,许少坚,等.2013-2017年深圳市龙华区手足口病流行病学及病原学特征分析[J].华南预防医学,2018,44(3):250-253. [11]颜湘,刘泉波.柯萨奇病毒A 组6 型与肠道病毒71型感染所致的手足口病临床特点比较[J].中国循证儿科杂志,2015,10(3):206-209. [12]郑振喜,张晓丽,钟晓,等.CVA6型手足口病临床特征分析[J].临床医学工程,2015(7):48-49,52. [13]刘莹莹,于秋丽,赵文娜,等.河北省手足口病伴脱甲症的流行特征分析[J].疾病监测,2015,30(12):1036-1039.
相似文献/References:
[1]覃 艺,邓燕艺,赖昌生,等.手足口病患儿体内免疫球蛋白、补体、C反应蛋白及刺激分析CD80、CD86水平的临床意义及其与丙种球蛋白治疗疗效的关系[J].医学信息,2018,31(02):63.[doi:10.3969/j.issn.1006-1959.2018.02.022]
Qin Yi,DENG Yan-yi,LAI Chang-sheng,et al.Clinical Significance of Immunoglobulin,Complement,C-reactive Protein and CD80,CD86 in Children with Hand-foot-mouth Disease and their Relationship with Therapeutic Effect of Gamma Globulin[J].Medical Information,2018,31(13):63.[doi:10.3969/j.issn.1006-1959.2018.02.022]
[2]李 淼,孙浩淼,纵书芳,等.徐州地区2015~2016年手足口病流行病学特征分析[J].医学信息,2018,31(02):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
LI Miao,SUN Hao-miao,ZONG Shu-fang,et al.Epidemiological Characteristics of Hand-foot-mouth Disease in Xuzhou Area in 2015 to 2016[J].Medical Information,2018,31(13):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
[3]任燕.手足口病患儿血清淋巴细胞免疫分型的水平变化及临床意义[J].医学信息,2018,31(01):82.[doi:10.3969/j.issn.1006-1959.2018.01.029]
REN Yan.Serum Level of Lymphocyte Immunophenotype in Children with Hand-foot-mouth Disease
and its Clinical Significance[J].Medical Information,2018,31(13):82.[doi:10.3969/j.issn.1006-1959.2018.01.029]
[4]覃 艺,邓燕艺,赖昌生,等.554例儿童重症手足口病的临床特征分析[J].医学信息,2018,31(11):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
QIN Yi,DENG Yan-yi,LAI Chang-sheng,et al.Analysis of Clinical Features of Severe Hand Foot and Mouth Disease in 554 Children[J].Medical Information,2018,31(13):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
[5]兰文林,白宝鑫,石武祥.手足口病研究进展及防治措施[J].医学信息,2018,31(15):29.[doi:10.3969/j.issn.1006-1959.2018.15.011]
LAN Wen-lin,BAO Bao-xin,SHI Wu-xiang.Research Progress and Control Measures of Hand-Foot-Mouth Disease[J].Medical Information,2018,31(13):29.[doi:10.3969/j.issn.1006-1959.2018.15.011]
[6]刘 娜,闫卫利.2016年我院儿童病院肠道病毒71型感染情况调查[J].医学信息,2018,31(15):115.[doi:10.3969/j.issn.1006-1959.2018.15.036]
LIU Na,YAN Wei-li.Investigation of Human Enterovirus 71 Infection in our Children's Hospital in 2016[J].Medical Information,2018,31(13):115.[doi:10.3969/j.issn.1006-1959.2018.15.036]
[7]管 建,姜娟娟.血清IL-6、IL-10、CRP和PCT水平检测对手足口病早期
合并细菌感染患儿的临床诊断价值[J].医学信息,2018,31(15):146.[doi:10.3969/j.issn.1006-1959.2018.15.047]
GUAN Jian,JIANG Juan-juan.Clinical Diagnostic Value of Serum Levels of IL-6,IL-10,CRP and PCT in Children with Hand-Foot-and-Mouth Disease Combined with Early Bacterial Infection[J].Medical Information,2018,31(13):146.[doi:10.3969/j.issn.1006-1959.2018.15.047]
[8]李正兰.重组人干扰素α1b治疗小儿手足口病的临床疗效观察[J].医学信息,2019,32(05):156.[doi:10.3969/j.issn.1006-1959.2019.05.050]
LI Zheng-lan.Clinical Observation of Recombinant Human Interferon α1b in the Treatment of Hand-Foot-Mouth Disease in Children[J].Medical Information,2019,32(13):156.[doi:10.3969/j.issn.1006-1959.2019.05.050]
[9]陆志刚,梁 洁,钟 敏.新疆第八师石河子市2015~2018年手足口病原学特征及病流行病学分析[J].医学信息,2019,32(06):82.[doi:10.3969/j.issn.1006-1959.2019.06.026]
LU Zhi-gang,LIANG Jie,ZHONG Min.Epidemiological Characteristics and Epidemiological Analysis of Hand,Foot and Mouth in Shihezi City,the Eighth Division of Xinjiang from 2015 to 2018[J].Medical Information,2019,32(13):82.[doi:10.3969/j.issn.1006-1959.2019.06.026]
[10]张小华,敏 峰,张玲丽.喜炎平联合单磷酸阿糖腺苷治疗小儿手足口病的
效果及安全性[J].医学信息,2019,32(15):157.[doi:10.3969/j.issn.1006-1959.2019.15.052]
ZHANG Xiao-hua,MIN Feng,ZHANG Ling-li.Application Effect and Safety of Xiyanping Combined with Adenosine Monophosphate in
the Treatment of Hand,Foot and Mouth Disease in Children[J].Medical Information,2019,32(13):157.[doi:10.3969/j.issn.1006-1959.2019.15.052]
[11]王 颖.手足口病聚集性疫情的病原学特征及流行病学调查[J].医学信息,2022,35(07):162.[doi:10.3969/j.issn.1006-1959.2022.07.042]
WANG Ying.Etiological Characteristics and Epidemiological Investigation of Hand-feet-mouth Disease Clustering Epidemics[J].Medical Information,2022,35(13):162.[doi:10.3969/j.issn.1006-1959.2022.07.042]